UBS raised the firm’s price target on Marvell (MRVL) to $115 from $110 and keeps a Buy rating on the shares. Marvell’s guidance was well ahead of Street expectations, raising the trajectory for its AI-levered businesses heading into FY26, while the recovery in its traditional merchant businesses continues to unfold, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRVL:
- Marvell price target raised to $127 from $122 at Evercore ISI
- Marvell price target raised to $102 from $82 at Morgan Stanley
- Marvell price target raised to $125 from $95 at KeyBanc
- Marvell price target raised to $130 from $110 at Wells Fargo
- China retaliates against U.S. chip restrictions, FT reports